Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma

Washington University School of Medicine · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
recurrent head and neck squamous cell carcinoma, metastatic head and neck squamous cell carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 895433
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.